Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by Korea Otsuka Pharmaceutical Co.,Ltd..
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Information provided by:
Korea Otsuka Pharmaceutical Co.,Ltd.
ClinicalTrials.gov Identifier:
NCT00549952
First received: October 25, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted

October 25, 2007
October 25, 2007
October 2007
Not Provided
incidence and severity of oral mucositis
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Oral Mucositis
Other: no intervention study
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
March 2008
Not Provided

Inclusion Criteria:

  • Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

Exclusion Criteria:

  • Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
  • Patients with performance status of ECOG score is more than 3
Both
19 Years and older
No
Contact: Yonghui Jeong 82-2-3465-3956 jeongyh@otsuka.co.kr
Contact: Boyoun Seo 82-2-3465-5485 byseo@otsuka.cokr
Korea, Republic of
 
NCT00549952
256-KOB-0701
No
Not Provided
Korea Otsuka Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical Co., Ltd.
Principal Investigator: Do-Youn Oh, PhD Seoul National University Hospital
Korea Otsuka Pharmaceutical Co.,Ltd.
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP